155 related articles for article (PubMed ID: 10973316)
21. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
[TBL] [Abstract][Full Text] [Related]
22. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo.
Lian JB; Balint E; Javed A; Drissi H; Vitti R; Quinlan EJ; Zhang L; Van Wijnen AJ; Stein JL; Speck N; Stein GS
J Cell Physiol; 2003 Aug; 196(2):301-11. PubMed ID: 12811823
[TBL] [Abstract][Full Text] [Related]
23. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice.
Schinke T; Gebauer M; Schilling AF; Lamprianou S; Priemel M; Mueldner C; Neunaber C; Streichert T; Ignatius A; Harroch S; Amling M
Bone; 2008 Mar; 42(3):524-34. PubMed ID: 18178537
[TBL] [Abstract][Full Text] [Related]
24. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production.
Bozec A; Bakiri L; Jimenez M; Schinke T; Amling M; Wagner EF
J Cell Biol; 2010 Sep; 190(6):1093-106. PubMed ID: 20837772
[TBL] [Abstract][Full Text] [Related]
25. [Influence of stretch strain and pressure on expression of osteoblasts' FOS protein].
Zhang X; Guo Y; Li R; Zhao Y; Wu J; Guan J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):326-8. PubMed ID: 16706358
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
28. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
29. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
30. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
[TBL] [Abstract][Full Text] [Related]
31. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
32. Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism.
Bozec A; Bakiri L; Jimenez M; Rosen ED; Catalá-Lehnen P; Schinke T; Schett G; Amling M; Wagner EF
J Cell Sci; 2013 Dec; 126(Pt 23):5432-40. PubMed ID: 24046454
[TBL] [Abstract][Full Text] [Related]
33. Bone Fos-silization.
Weitzman J
Trends Mol Med; 2001 Jan; 7(1):10. PubMed ID: 11427972
[No Abstract] [Full Text] [Related]
34. Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass.
Sims NA; Sabatakos G; Chen JS; Kelz MB; Nestler EJ; Baron R
Bone; 2002 Jan; 30(1):32-9. PubMed ID: 11792562
[TBL] [Abstract][Full Text] [Related]
35. Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity.
Sabatakos G; Rowe GC; Kveiborg M; Wu M; Neff L; Chiusaroli R; Philbrick WM; Baron R
J Bone Miner Res; 2008 May; 23(5):584-95. PubMed ID: 18433296
[TBL] [Abstract][Full Text] [Related]
36. How many factors are required to remodel bone?
Karsenty G
Nat Med; 2000 Sep; 6(9):970-1. PubMed ID: 10973309
[No Abstract] [Full Text] [Related]
37. Osteoblasts are target cells for transformation in c-fos transgenic mice.
Grigoriadis AE; Schellander K; Wang ZQ; Wagner EF
J Cell Biol; 1993 Aug; 122(3):685-701. PubMed ID: 8335693
[TBL] [Abstract][Full Text] [Related]
38. Essential role of RSK2 in c-Fos-dependent osteosarcoma development.
David JP; Mehic D; Bakiri L; Schilling AF; Mandic V; Priemel M; Idarraga MH; Reschke MO; Hoffmann O; Amling M; Wagner EF
J Clin Invest; 2005 Mar; 115(3):664-72. PubMed ID: 15719069
[TBL] [Abstract][Full Text] [Related]
39. [Overexpression of the truncated fosb isoform (Delta2Deltafosb) increases nodus in CD1 primary osteoblastes].
Zheng HL; Yuan C; Bao LJ; An JH; Zhu ZZ; Yang GS
Fen Zi Xi Bao Sheng Wu Xue Bao; 2008 Jun; 41(3):222-6. PubMed ID: 18630601
[TBL] [Abstract][Full Text] [Related]
40. The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels.
Kveiborg M; Chiusaroli R; Sims NA; Wu M; Sabatakos G; Horne WC; Baron R
Endocrinology; 2002 Nov; 143(11):4304-9. PubMed ID: 12399426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
